- Filed
- Nov 13, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Stockholders Equity | Q2 2024 · Sep 30, 2024 | $52.67M |
| Stockholders Equity | Q2 2024 · Mar 31, 2024 | $58.84M |
| Stockholders Equity | Q2 2024 · Sep 30, 2023 | $70.71M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $81.18M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $79.81M |
| Current Liabilities | Q2 2024 · Sep 30, 2024 | $3.18M |
| Current Liabilities | Q2 2024 · Mar 31, 2024 | $931K |
| Total Liabilities | Q2 2024 · Sep 30, 2024 | $8.33M |
| Total Liabilities | Q2 2024 · Mar 31, 2024 | $996K |
| Current Assets | Q2 2024 · Sep 30, 2024 | $32.54M |
| Current Assets | Q2 2024 · Mar 31, 2024 | $59.7M |
| Total Assets | Q2 2024 · Sep 30, 2024 | $80.28M |
| Total Assets | Q2 2024 · Mar 31, 2024 | $59.84M |
| Revenue | Q2 2024 · Sep 30, 2024 | $2.96M |
| Revenue | Q2 2024 · Sep 30, 2024 | $3.45M |
| Revenue | Q2 2024 · Sep 30, 2023 | $0 |
| Revenue | Q2 2024 · Sep 30, 2023 | $0 |
| Shares Diluted | Q2 2024 · Sep 30, 2023 | 7.29M sh |
| Shares Diluted | Q2 2024 · Sep 30, 2023 | 7.29M sh |
| Capex | Q2 2024 · Sep 30, 2023 | $13K |
| Operating Cash Flow | Q2 2024 · Sep 30, 2023 | $1.45M |
| Eps Diluted | Q2 2024 · Sep 30, 2023 | −$1.44 |
| Eps Diluted | Q2 2024 · Sep 30, 2023 | −$1.23 |
| Eps Basic | Q2 2024 · Sep 30, 2023 | −$1.44 |
| Eps Basic | Q2 2024 · Sep 30, 2023 | −$1.23 |
| Sga Expense restated | Q2 2024 · Sep 30, 2023 | $1.59M |
| Sga Expense restated | Q2 2024 · Sep 30, 2023 | $3.07M |
| Net Income | Q2 2024 · Sep 30, 2023 | −$10.49M |
| Net Income | Q2 2024 · Sep 30, 2023 | −$8.93M |
| Operating Income | Q2 2024 · Sep 30, 2023 | −$1.61M |
| Operating Income | Q2 2024 · Sep 30, 2023 | −$3.11M |